Edition:
United States

Agile Therapeutics Inc (AGRX.OQ)

AGRX.OQ on NASDAQ Stock Exchange Global Market

0.57USD
22 Jun 2018
Change (% chg)

$-0.01 (-1.72%)
Prev Close
$0.58
Open
$0.59
Day's High
$0.59
Day's Low
$0.56
Volume
87,088
Avg. Vol
70,821
52-wk High
$5.59
52-wk Low
$0.54

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.200
FY 2017 Dec '17 0.00 -0.182
Sep '17 0.00 -0.222
Jun '17 0.00 -0.259
Mar '17 0.00 -0.261
FY 2016 Dec '16 0.00 -0.181
Sep '16 0.00 -0.271
Jun '16 0.00 -0.293
Mar '16 0.00 -0.273
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 0.00 0.00 0.00 --
Quarter Ending Sep-18 5 0.00 0.00 0.00 --
Year Ending Dec-18 5 0.00 0.00 0.00 34.72
Year Ending Dec-19 5 11.81 29.74 0.00 106.29
Earnings (per share)
Quarter Ending Jun-18 5 -0.17 -0.16 -0.19 --
Quarter Ending Sep-18 5 -0.16 -0.14 -0.18 --
Year Ending Dec-18 5 -0.67 -0.65 -0.70 -0.68
Year Ending Dec-19 5 -0.76 -0.27 -1.17 0.74
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 82.81 32.74
P/E High - Last 5 Yrs. -- 289.15 45.73
P/E Low - Last 5 Yrs. -- 90.24 24.23
Beta 2.07 0.91 0.88
Price to Sales (TTM) -- 109.18 5.71
Price to Book (MRQ) 5.23 13.44 5.37
Price to Tangible Book (MRQ) 6.20 13.96 6.94
Price to Cash Flow (TTM) -- 70.39 23.32
% Owned Institutions 78.05 13.84 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.34 1.50
Dividend Yield - 5 Year Avg -- 0.25 1.51
Dividend 5 Year Growth Rate -- 1.64 5.32
Payout Ratio(TTM) -- 15.83 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 392.54 7.89
Sales (TTM) vs TTM 1 Yr. Ago -- 77.35 5.68
Sales - 5 Yr. Growth Rate -- 32.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 11.73 24.53 19.38
EPS (TTM) vs TTM 1 Yr. Ago 16.43 -- --
EPS - 5 Yr. Growth Rate -- 39.08 10.78
Capital Spending - 5 Yr. Growth Rate -- 40.34 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.83 2.19
Current Ratio (MRQ) 3.37 5.26 2.98
LT Debt to Equity (MRQ) 27.06 24.54 12.19
Total Debt to Equity (MRQ) 47.59 26.17 16.46
Interest Coverage (TTM) -15.94 -97.42 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.81 54.46
Gross Margin - 5 Yr. Avg. -- 51.76 52.22
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -564.12 10.98
Operating Margin (TTM) -- -706.11 4.74
Operating Margin - 5 Yr. Avg. -- -585.15 6.41
Pre-Tax Margin (TTM) -- -681.03 5.58
Pre-Tax Margin - 5 Yr. Avg. -- -588.45 6.83
Net Profit Margin (TTM) -- -682.46 1.88
Net Profit Margin - 5 Yr. Avg. -- -591.46 3.10
Effective Tax Rate (TTM) -- 22.64 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.26 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,312,275 846,855,748
Net Income/Employee (TTM) -1,471,947 2,947,385 99,619,396
Receivable Turnover (TTM) -- 19.92 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.00 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -46.27 -0.70 10.95
Return on Assets - 5 Yr. Avg. -- -0.06 12.32
Return on Investment (TTM) -55.62 2.00 14.38
Return on Investment - 5 Yr. Avg. -- 2.81 16.11
Return on Equity (TTM) -67.67 3.49 16.08
Return on Equity - 5 Yr. Avg. -- 4.33 17.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 26.22 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Agile Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 77.79%
# of Holders: 58
Total Shares Held: 26,640,469
3 Mo. Net Change: -950,961
# New Positions: 6
# Closed Positions: 10
# Increased Positions: 21
# Reduced Positions: 26
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.